Research use only · Not for human consumptionPepwizard compares vendor pricing for research-grade compounds. Nothing on this site is medical advice. How we price.
Compound sheet
Fat Loss / GHRH 1-44 analogue
07.05.2026
FAT LOSSLow availability
Tesamorelin
GHRH 1-44 analogue · 44aa · aka "Egrifta"
“Visceral-fat-specific GHRH. FDA-approved for HIV lipodystrophy.”
No offers tracked yet.
§ 01 — Spec
Amino acids
44
Half-life
~26 minutes
Admin
Subcutaneous
Typical dose
1–2 mg subcutaneous daily
Live offers
0
§ 02 — Abstract
An FDA-approved growth-hormone-releasing hormone analogue for HIV-associated lipodystrophy, used off-label for visceral fat reduction and metabolic health.
Tesamorelin is a stabilised GHRH analogue with a longer half-life than sermorelin. It selectively reduces visceral adipose tissue (VAT) while preserving subcutaneous fat and lean mass.
Studied for
01Significant visceral fat reduction (15–20% in trials)
02Improved lipid profile
03Better glucose tolerance
04Lean mass preservation
§ Codes
Live coupon for Tesamorelin.
§ 03 — Stock
No approved vendor stocks Tesamorelin yet.
We only feature vendors whose affiliate programmes we've signed off — no inventory padding. We're onboarding more partners and will list Tesamorelin as soon as one stocks it.
Email me when it lists
We'll ping you the moment a tracked vendor lists Tesamorelin.
Free · weekly
Your email. That's it. No account. No tracking pixels. Unsubscribe anytime.
§ 04 — Trend
Tracking begins.
We started tracking Tesamorelin on 2026-05-07. The chart unlocks at 14 daily snapshots — currently 1 on file.
1 snapshot · floor on 07.05.2026